Literature DB >> 24598671

[Immunomodulatory effect of UC-MSC on function of immunocytes of rats with collagen type II induced arthritis].

Jian Gu1, Chuan-Ming Lin2, Wei Gu3, Xin-Zhen Cai3, Zou Li4, Min-Min Ren4, Xing Sun4, Jun Ni4, Lian-Jun Shen4, Wei Wu4, Bin He4, Mei Sun4, Yu Zhang4.   

Abstract

This study was purposed to observe the influence of umbilical cord mesenchymal stem cells (UC-MSC) on the peripheral blood CD4(+)CD25(+)regulatory T cells (Treg), Th17 cells and neutrophils in rats with collagen type II-induced arthritis(CIA), and to explore the regulating effect of UC-MSC transplantation on immunocyte subgroup. The rats wee divided into 3 groups: CIA group (model group), UC-MSC treated group and blank control group. The CIA rats were injected with UC-MSC via tail vein. The percentage of CD4(+)CD25(+) cells in peripheral blood and the expression of NCD11b on neutrophil surface in CIA rates was detected by flow cytometry (FCM), and the serum interleukin-17 (IL-17) was observed by enzyme-linked immunosorbent assay (ELISA). The results showed that the mean fluorescence intensity(MFI) of NCD11b and the level of IL-17 in the model group were significantly higher than those in the blank control group, and the ratio of CD4(+)CD25(+) cells were significantly lower (P < 0.05). The MIF of NCD11b and the level of IL-17 in the UC-MSC treated group were significantly lower than that in the model group (P < 0.05), while the proportion of CD4(+)CD25(+) Treg increased (P < 0.05). Since the fifth week, the above indicators in the UC-MSC group have almostly approached the control group. It is concluded that the UC-MSC can increase peripheral blood Treg proportion in CIA rat, inhibit the secretion of Th17 and the activity of neutrophils, reduce the immune inflammation reaction, decrease the release of proinflammatory factor, and induce immune reconstruction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24598671     DOI: 10.7534/j.issn.1009-2137.2014.01.032

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  3 in total

1.  Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis.

Authors:  Ai Li; Yuan Tao; Dexiao Kong; Ni Zhang; Yongjing Wang; Zhilun Wang; Yingxue Wang; Juandong Wang; Juan Xiao; Yang Jiang; Xiaoli Liu; Chengyun Zheng
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

2.  The Promising Effects of Transplanted Umbilical Cord Mesenchymal Stem Cells on the Treatment in Traumatic Brain Injury.

Authors:  Lifeng Qi; Xinhong Xue; Jijun Sun; Qingjian Wu; Hongru Wang; Yan Guo; Baoliang Sun
Journal:  J Craniofac Surg       Date:  2018-10       Impact factor: 1.046

Review 3.  Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges.

Authors:  Xiaolan Lv; Liming Wang; XiaoRong Zou; Shigao Huang
Journal:  Drug Des Devel Ther       Date:  2021-09-15       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.